📣 VC round data is live. Check it out!
Rianlon Valuation Multiples
Discover revenue and EBITDA valuation multiples for Rianlon
Rianlon Overview
About Rianlon
Rianlon Corp provides polymer additives and solutions for the polymer materials industry. Its product portfolio consists of General Antioxidants, Specialty Antioxidants, UV-Absorbers, Hindered Amine Light Stabilizers, and Blend Addtives.
Founded
2011
HQ
Employees
N/A
Website
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trial
Rianlon Financials
Rianlon reported last 12-month revenue of $931M and EBITDA of $153M.
In the same LTM period, Rianlon generated $216M in gross profit, $153M in EBITDA, and $79M in net income.
Rianlon P&L
In the most recent fiscal year, Rianlon reported revenue of $887M and EBITDA of $147M.
Rianlon is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 17%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
Rianlon Stock Performance
Rianlon has current market cap of $2B, and enterprise value of $2B.
Rianlon's stock price is $6.71.
Rianlon has an EPS (earnings per share) of $0.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 2.4% | — | — | — | $0.32 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRianlon Valuation Multiples
Rianlon trades at 2.0x EV/Revenue multiple, and 12.0x EV/EBITDA.
Rianlon Financial Valuation Multiples
As of May 15, 2026, Rianlon has market cap of $2B and EV of $2B.
Rianlon has a P/E ratio of 19.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Rianlon Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Rianlon Margins & Growth Rates
Rianlon grew revenue by 15% and EBITDA by 14% in the last fiscal year.
In the most recent fiscal year, Rianlon reported gross margin of 22%, EBITDA margin of 17%, and net margin of 8%.
Rianlon Margins
Rianlon Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Rianlon Operational KPIs
Rianlon's Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Rianlon's Rule of X is 53% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Rianlon Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Rianlon competitors and their valuation data. Start Free Trial | ||||||
Rianlon Investment Activity
Rianlon has invested in 3 companies to date.
Latest investment by Rianlon was on May 10th 2026. Rianlon invested in Plastic New Technology in their Series A round.
Latest Investments by Rianlon
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Heng Hai Kai Wu | |||
| Description | Plastic New Technology centers on enzymatic depolymerization and recycling of post-consumer waste polyester textiles and other polymeric materials. | Heng Hai Kai Wu is a biomanufacturing company leveraging proprietary in vitro biotransformation technology to produce food ingredients, health products, novel chemical materials, and enzyme preparations. | Yuantian Bio is a biotechnology company based in China specializing in enzymatic regeneration technologies and commercial applications for recycled plastic PET. It produces over ten low-cost enzyme preparations through fermentation and supports large-scale biochemical product manufacturing for industrial clients. |
| HQ Country |  | | |
| HQ City | Beijing | — | Tianjin |
| Deal Date | 10 May 2026 | 15 Jan 2026 | 16 Apr 2025 |
| Round | Series A | Seed | Seed |
| Raised | undisclosed | undisclosed | $14M |
| Investors | Fu Yuan Investment; Haitang Fund; Innoangel Fund; Rianlon; Shangshi Fund; Tianjin Renai Capital | Haitang Fund; Renai Jiasheng; Rianlon; Shangshi Fund | Dalton Venture; Haitang Fund; Rianlon; Shangshi Fund; Tianjin Renai Capital |
| Valuation | undisclosed | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Rianlon investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Rianlon
| When was Rianlon founded? | Rianlon was founded in 2011. |
| Where is Rianlon headquartered? | Rianlon is headquartered in China. |
| Is Rianlon publicly listed? | Yes, Rianlon is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Rianlon? | Rianlon trades under 300596 ticker. |
| When did Rianlon go public? | Rianlon went public in 2017. |
| Who are competitors of Rianlon? | Rianlon main competitors include |
| What is the current market cap of Rianlon? | Rianlon's current market cap is $2B. |
| What is the current revenue of Rianlon? | Rianlon's last 12 months revenue is $931M. |
| What is the current revenue growth of Rianlon? | Rianlon revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Rianlon? | Current revenue multiple of Rianlon is 2.0x. |
| Is Rianlon profitable? | Yes, Rianlon is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Rianlon? | Rianlon's last 12 months EBITDA is $153M. |
| What is Rianlon's EBITDA margin? | Rianlon's last 12 months EBITDA margin is 16%. |
| What is the current EV/EBITDA multiple of Rianlon? | Current EBITDA multiple of Rianlon is 12.0x. |
| How many companies Rianlon has acquired to date? | Rianlon hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Rianlon has invested to date? | As of May 2026, Rianlon has invested in 3 companies. |
| What was the last Rianlon investment? | On 10th May 2026 Rianlon invested in Plastic New Technology, participating in a Series A round, alongside Fu Yuan Investment, Haitang Fund, Innoangel Fund, Shangshi Fund, and Tianjin Renai Capital. |
| In what companies Rianlon invested in? | Rianlon invested in Yuantian Bio, Heng Hai Kai Wu, and Plastic New Technology. |
Lists including Rianlon
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.